AzTrials
AzTrials

Rhinoplasty TechniquesNCT07142525

Hybrid Osteoplasty Versus Osteotomy in Rhinoplasty

A study testing Hybrid Osteoplasty and Traditional Osteotomy and Rasping in people with Rhinoplasty Techniques, run by University of Sulaimani at 1 site in Iraq.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record

Search all trials

Trial summary

This study is designed to compare two common techniques for reducing the nasal hump during rhinoplasty: the traditional method using osteotomes and rasps, and a newer technique called hybrid osteoplasty that uses a surgical drill. Both approaches aim to improve the appearance and function of the nose. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Rhinoplasty Techniques
What is being tested?
Hybrid Osteoplasty and Traditional Osteotomy and Rasping
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteIraq
Study dates
1 Oct 2025to 1 Dec 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Primary open rhinoplasty planned.
  • Dorsal hump with bony or mixed component suitable for either technique.
  • No prior nasal surgery or significant nasal trauma affecting dorsum.
  • ASA I-III and fit for general anesthesia.
  • Willing to provide written informed consent, including standardized photography.
  • Able and willing to attend all follow-up visits through 12 months.

Who cannot join

  • Revision rhinoplasty or prior osteotomy/osseocartilaginous work.
  • Active infection, open lesions, or uncontrolled dermatologic conditions at operative field.
  • Bleeding diathesis, platelet disorder, INR elevation, or anticoagulant/antiplatelet therapy that cannot be paused.
  • Uncontrolled systemic disease (e.g., hypertension, diabetes) or ASA ≥ IV.
  • Pregnancy or breastfeeding.
  • Chronic isotretinoin use within past 6 months or long-term systemic corticosteroid use.
  • Concurrent interventional study that may affect healing or outcomes.

Trial locations and contacts

1 site in 1 country.

Iraq1 site
  • Royal Hospital

    Sulaymaniyah, KRI, 46001

Other trials in Iraq

About this study

Official title: Aesthetic and Functional Outcomes Following Hybrid Osteoplasty Versus Traditional Osteotomy in Rhinoplasty: A Randomized Controlled Trial

This study is designed to compare two common techniques for reducing the nasal hump during rhinoplasty: the traditional method using osteotomes and rasps, and a newer technique called hybrid osteoplasty that uses a surgical drill. Both approaches aim to improve the appearance and function of the nose. The trial will measure pain, swelling, bruising, and the smoothness of the nasal bridge, as well as patient satisfaction and breathing outcomes. Participants will be followed for one year to assess both early healing and long-term results.

Read the detailed description

This prospective randomized controlled trial will evaluate the aesthetic and functional outcomes of hybrid osteoplasty using a surgical burr compared with traditional osteotomy and rasping in primary open rhinoplasty patients presenting with dorsal humps. The study population consists of adults without prior nasal surgery, trauma, or congenital deformities. Patients are randomized into two groups: Group A (hybrid osteoplasty) and Group B (traditional osteotomy plus rasping).

The primary objective is to assess differences in postoperative pain, edema, ecchymosis, dorsal smoothness, contour regularity, and patient satisfaction. Secondary outcomes include functional improvement measured by the Nasal Obstruction Symptom Evaluation (NOSE) score, aesthetic satisfaction assessed by the Rhinoplasty Outcome Evaluation (ROE), and the rate of revision surgery within 12 months.

Follow-up assessments are scheduled on postoperative Days 1, 2, and 7, and at 1, 3, 6, and 12 months. Standardized photographic documentation will support aesthetic evaluation, while clinical scoring systems will provide objective and subjective outcome data. The trial is powered to identify whether hybrid osteoplasty offers advantages in contour refinement and reduced soft tissue trauma compared with conventional osteotomy-based approaches.

Being tested
Hybrid Osteoplasty, Traditional Osteotomy and Rasping
Keywords
Osteoplasty, Dorsal Hump, Rhinoplasty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hybrid OsteoplastyProcedure or surgery

    Also called Drill-Assisted Dorsal Hump Reduction, Power-Assisted Osteoplasty, Burr Osteoplasty

    Open rhinoplasty with dorsal hump reduction performed using a powered surgical burr under irrigation and direct visualization. Bone is contoured gradually to achieve a smooth dorsum while preserving the keystone area. No dorsal osteotomy is performed in this arm. Cartilaginous work and adjunctive steps (e.g., septoplasty or tip refinement) are performed as clinically indicated but are not part of the intervention being tested.

  • Traditional Osteotomy and RaspingProcedure or surgery

    Also called Osteotome + Rasp Technique, Conventional Dorsal Hump Reduction

    Open rhinoplasty using the conventional technique for dorsal hump reduction. The bony hump is resected with a straight osteotome, followed by manual rasping to refine the nasal dorsum, with preservation of the keystone area. Powered burrs are not used for primary dorsal contouring in this arm. Cartilaginous work and adjunctive procedures may be performed as clinically indicated but are not part of the tested intervention.

Study groups in NCT07142525
Study groupRoleWhat they receive
Hybrid OsteoplastyExperimentalParticipants undergo dorsal hump reduction using a surgical burr (drill) without traditional dorsal osteotomy. The technique allows controlled bone contouring under direct visualization.
Receives: Procedure: Hybrid Osteoplasty
Traditional Osteotomy and RaspingActive comparatorParticipants undergo dorsal hump reduction using the conventional method of osteotomy combined with rasping. This is the established standard approach for contouring the nasal dorsum.
Receives: Procedure: Traditional Osteotomy and Rasping

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Change in Rhinoplasty Outcome Evaluation (ROE) Score from Baseline to 12 Months

    ROE (Rhinoplasty Outcome Evaluation) questionnaire scored 0-100 (higher = greater satisfaction). Score calculated per instrument guidance from the 6 items, converted to 0-100. Change is 12-month minus preoperative score.

    Measured: Baseline (preoperative) and 12 months post-operation.

  2. Mean Dorsal Contour Irregularity Score on Blinded Photographic Assessment at 12 Months

    Standardized 7-view photographs rated by three blinded surgeons using a 4-point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe irregularity). Primary analysis compares group means; inter-rater agreement assessed.

    Measured: 12 months post-operation.

  3. Mean Periorbital Edema Score on 4-Point Clinician Scale at Day 1 and Day 7

    3 Clinicians-rated 4-point edema scale (0 = none, 1 = mild, 2 = moderate, 3 = severe).

    Measured: Post-op Day 1 and Day 7.

  4. Mean Periorbital Ecchymosis Score on 4-Point Clinician Scale at Day 1 and Day 7

    3 Clinician-rated 4-point ecchymosis scale (0-3).

    Measured: Post-op Day 1 and Day 7.

  5. Proportion of Participants with Residual Hump or Dorsal Depression on Blinded Photographic Assessment at 12 Months

    Blinded photographic assessment for remnant hump or depression (present/absent), by 3 assessors.

    Measured: 12 months post-operation

  6. Proportion of Participants with Nasal Dorsum Width Symmetry at 12 Months

    Symmetry rated by 3 blinded assessors on 3-point scale (symmetric / mildly asymmetric / asymmetric)

    Measured: 12 months post-operation

  7. Number of Participants Requiring Unplanned Revision Surgery within 12 Months

    Any unplanned surgical revision related to the nasal dorsum

    Measured: Within 12 months post-operation

Secondary outcomes (4)
  1. Proportion of Participants with Smooth Nasal Dorsum (Non-Blinded Binary Assessment) at 12 Months

    Smooth vs Irregular, reported by 3 assessors

    Measured: 12 months post-operation

  2. Mean Change in Nasal Obstruction Symptom Evaluation (NOSE) Score from Baseline to 12 Months

    NOSE questionnaire scored 0-100 (higher = worse obstruction). Change is 12-month minus preoperative score; negative values indicate improvement.

    Measured: Baseline (preoperative) and 12 months post-operation.

  3. Mean Pain Score on 0-10 Visual Analogue Scale at Post-Op Day 0 and Day 7

    Pain measured on a 0-10 visual analogue scale (higher = more pain)

    Measured: Post-op Day 0 and Day 7

  4. Proportion of Participants with Palpable or Visible Dorsal Callus on Clinical Exam at 3 and 6 Months

    Presence of palpable or visible dorsal callus on clinical exam (Yes/No). 3 assessors.

    Measured: 3 and 6 months post-operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2025
  2. Study start1 Oct 2025
  3. Primary completion1 Dec 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07142525
Sponsor's protocol ID
No. 159 (August 17th, 2025)
Status last verified
Jul 2026
First submitted
19 Aug 2025
Last updated
27 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data (IPD) underlying the published results will be shared, including baseline demographic information, surgical technique allocation, intraoperative variables, and postoperative outcome measures (pain scores, edema, ecchymosis, ROE scores, NOSE scores, blinded photographic assessments, and revision status). Data will be available in de-identified form upon reasonable request to the principal investigator after publication of the primary results. Supporting documents, including the study protocol and statistical analysis plan, will also be made available.

Publications

  • Azizli E, Bayar Muluk N, Dundar R, Cingi C. A new preservation technique for dehumping the dorsum. Eur Rev Med Pharmacol Sci. 2023 Mar;27(2 Suppl):57-62. doi: 10.26355/eurrev_202303_31703.

    PubMed 36971222
  • Ferreira MG, Monteiro D, Reis C, Almeida e Sousa C. Spare Roof Technique: A Middle Third New Technique. Facial Plast Surg. 2016 Feb;32(1):111-6. doi: 10.1055/s-0035-1570503. Epub 2016 Feb 10.

    PubMed 26862972
  • Aldosari BF, Alhajress RI, Bogari AO. Hump Rasping Using Powered Instruments: A Retrospective Review. Plast Reconstr Surg Glob Open. 2024 Sep 10;12(9):e6153. doi: 10.1097/GOX.0000000000006153. eCollection 2024 Sep.

    PubMed 39258281
  • Lal GN, Ghosh P. Use of drill in rhinoplasty (a case report). Indian J Otolaryngol Head Neck Surg. 1999 Jan;51(1):90-2. doi: 10.1007/BF02996859.

    PubMed 23119498
  • Goodman WS. The rotating burr in rhinoplasty. Arch Otolaryngol. 1981 Jul;107(7):436-8. doi: 10.1001/archotol.1981.00790430038010. No abstract available.

    PubMed 7247809
  • Avashia YJ, Marshall AP, Allori AC, Rohrich RJ, Marcus JR. Decision-Making in Middle Vault Reconstruction following Dorsal Hump Reduction in Primary Rhinoplasty. Plast Reconstr Surg. 2020 Jun;145(6):1389-1401. doi: 10.1097/PRS.0000000000006850.

    PubMed 32195860
  • Barrett DM, Casanueva F, Wang T. Understanding Approaches to the Dorsal Hump. Facial Plast Surg. 2017 Apr;33(2):125-132. doi: 10.1055/s-0037-1598033. Epub 2017 Apr 7.

    PubMed 28388791
  • Fuller JC, Hilger PA. Modified Skoog Method for Hump Reduction. Facial Plast Surg Clin North Am. 2021 Feb;29(1):131-139. doi: 10.1016/j.fsc.2020.09.008.

    PubMed 33220838
  • Sowder JC, Thomas AJ, Gonzalez CD, Limaye NS, Ward PD. Use of Spreader Flaps Without Dorsal Hump Reduction and the Effect on Nasal Function. JAMA Facial Plast Surg. 2017 Jul 1;19(4):287-292. doi: 10.1001/jamafacial.2016.2057.

    PubMed 28241228
  • Azizzadeh B, Reilly M. Dorsal Hump Reduction and Osteotomies. Clin Plast Surg. 2016 Jan;43(1):47-58. doi: 10.1016/j.cps.2015.09.022. Epub 2015 Oct 23.

    PubMed 26616694
  • Roostaeian J, Unger JG, Lee MR, Geissler P, Rohrich RJ. Reconstitution of the nasal dorsum following component dorsal reduction in primary rhinoplasty. Plast Reconstr Surg. 2014 Mar;133(3):509-518. doi: 10.1097/01.prs.0000438453.29980.36.

    PubMed 24263393
  • Rohrich RJ, Muzaffar AR, Janis JE. Component dorsal hump reduction: the importance of maintaining dorsal aesthetic lines in rhinoplasty. Plast Reconstr Surg. 2004 Oct;114(5):1298-308; discussion 1309-12. doi: 10.1097/01.prs.0000135861.45986.cf.

    PubMed 15457053

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in